A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We have been a developer and manufacturer of advanced optical instruments since 1982, and we operate primarily in two key market segments: medical devices and advanced defense/aerospace products. Within our proprietary optical and imaging technology, our unique custom designs, expert manufacturing capabilities, and advanced engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using CMOS sensor technology, some designed and manufactured for single-use, as well as other, more advanced, custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. We design and manufacture ultra-high precision endoscopes and very small Microprecision lenses, assemblies and complete medical devices to meet the surgical community’s continuing demand for smaller, disposable, and more enhanced imaging systems for minimally invasive surgery.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 24M | 19M | 19M | 21M | 16M | 11M |
| Net Income | -6.9M | -5.8M | -3.0M | -145K | -928K | -103K |
| EPS | $-0.93 | $-0.85 | $-0.49 | $-0.03 | $-0.18 | $-0.01 |
| Free Cash Flow | 0 | -3.8M | -3.0M | -98K | -1.0M | -29K |
| ROIC | -58.1% | - | - | - | - | - |
| Gross Margin | 9.7% | 17.8% | 30.3% | 36.8% | 31.4% | 32.2% |
| Debt/Equity | 0.17 | - | - | - | - | - |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -6.7M | -5.6M | -2.7M | -639K | -1.5M | -906K |
| Operating Margin | -27.6% | -29.1% | -14.3% | -3.0% | -9.7% | -8.5% |
| ROE | -74.1% | - | - | - | - | - |
| Shares Outstanding | 8M | 7M | 6M | 5M | 5M | 10M |
PRECISION OPTICS CORPORATION, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 29.7%. At current prices, the estimated annualized return to fair value is -21.7%.
PRECISION OPTICS CORPORATION, INC. (POCI) has a market capitalization of $33M. It is classified as a small-cap stock.
PRECISION OPTICS CORPORATION, INC. (POCI) does not currently pay a regular dividend.
PRECISION OPTICS CORPORATION, INC. (POCI) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
PRECISION OPTICS CORPORATION, INC. (POCI) reported annual revenue of $19 million in its most recent fiscal year, based on SEC EDGAR filings.
PRECISION OPTICS CORPORATION, INC. (POCI) has a net profit margin of -30.3%. The company is currently unprofitable.
PRECISION OPTICS CORPORATION, INC. (POCI) generated $-4 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
PRECISION OPTICS CORPORATION, INC. (POCI) reported earnings per share (EPS) of $-0.85 in its most recent fiscal year.
PRECISION OPTICS CORPORATION, INC. (POCI) has a 5-year average gross margin of 29.7%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 15 years of financial data for PRECISION OPTICS CORPORATION, INC. (POCI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.